A Fluorescent Peptide Toxin for Selective Visualization of the Voltage-Gated Potassium Channel K V 1.3.
Dorothy C C WaiMuhammad Umair NaseemGábor MocsárSanjeevini Babu ReddiarYijun PanAgota CsotiPeter HajduCameron NowellJoseph A NicolazzoGyorgy PanyiRaymond S NortonPublished in: Bioconjugate chemistry (2022)
Upregulation of the voltage-gated potassium channel K V 1.3 is implicated in a range of autoimmune and neuroinflammatory diseases, including rheumatoid arthritis, psoriasis, multiple sclerosis, and type I diabetes. Understanding the expression, localization, and trafficking of K V 1.3 in normal and disease states is key to developing targeted immunomodulatory therapies. HsTX1[R14A], an analogue of a 34-residue peptide toxin from the scorpion Heterometrus spinifer , binds K V 1.3 with high affinity (IC 50 of 45 pM) and selectivity (2000-fold for K V 1.3 over K V 1.1). We have synthesized a fluorescent analogue of HsTX1[R14A] by N-terminal conjugation of a Cy5 tag. Electrophysiology assays show that Cy5-HsTX1[R14A] retains activity against K V 1.3 (IC 50 ∼ 0.9 nM) and selectivity over a range of other potassium channels (K V 1.2, K V 1.4, K V 1.5, K V 1.6, K Ca 1.1 and K Ca 3.1), as well as selectivity against heteromeric channels assembled from K V 1.3/K V 1.5 tandem dimers. Live imaging of CHO cells expressing green fluorescent protein-tagged K V 1.3 shows co-localization of Cy5-HsTX1[R14A] and K V 1.3 fluorescence signals at the cell membrane. Moreover, flow cytometry demonstrated that Cy5-HsTX1[R14A] can detect K V 1.3-expressing CHO cells. Stimulation of mouse microglia by lipopolysaccharide, which enhances membrane expression of K V 1.3, was associated with increased staining by Cy5-HsTX1[R14A], demonstrating that it can be used to identify K V 1.3 in disease-relevant models of inflammation. Furthermore, the biodistribution of Cy5-HsTX1[R14A] could be monitored using ex vivo fluorescence imaging of organs in mice dosed subcutaneously with the peptide. These results illustrate the utility of Cy5-HsTX1[R14A] as a tool for visualizing K V 1.3, with broad applicability in fundamental investigations of K V 1.3 biology, and the validation of novel disease indications where K V 1.3 inhibition may be of therapeutic value.
Keyphrases
- multiple sclerosis
- flow cytometry
- fluorescence imaging
- poor prognosis
- induced apoptosis
- living cells
- rheumatoid arthritis
- quantum dots
- escherichia coli
- photodynamic therapy
- type diabetes
- cell cycle arrest
- oxidative stress
- inflammatory response
- cardiovascular disease
- high resolution
- air pollution
- risk assessment
- long non coding rna
- immune response
- computed tomography
- heavy metals
- skeletal muscle
- spinal cord injury
- amino acid
- lps induced
- ankylosing spondylitis
- small molecule
- clinical evaluation
- wild type